Abstract:Inflammation, an important biological protective response to tissue damage or microbial invasion, is considered to be an alarming signal for the progress of varied biological complications. Based on the previous reports in the literature that proved the noticeable efficacy of pyrazole and thiazole scaffold as well as nitrogen heterocyclic based compounds against acute and chronic inflammatory disease, a new set of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazole derivatives were synthesized and evaluated their anti-inflammatory activities in vitro. Preliminary structure-activity relationship (SAR) analysis was conducted by their inhibitory activities against nitric oxide (NO) release in lipopolysaccharide (LPS)-induced RAW 264.7 cells, and the optimal compound 12b [3β-hydroxy-pregn-5-en-17β-yl-5'- (o- chlorophenyl)- 1'-(4''- phenyl -[1'', 3'']- thiazol-2''- yl) - 4',5'-dihydro - 1'H-pyrazol - 3'- yl] exhibited more potent anti-inflammatory activity than the positive control treatment methylprednisolone (MPS), with an IC50 value of 2.59 μM on NO production and low cytotoxicity against RAW 264.7 cells. In further mechanism study, our results showed that compound 12b significantly suppressed the production of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and inhibited the expressions of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) through blocking NF-κB p65 nuclear translocation and phosphorylation of IκBα. Compound 12b also attenuated LPS-induced activation of c-Jun amino-terminal kinase (JNK) and p38 phosphorylation in RAW 264.7 cells. Molecular docking study revealed the strong binding affinity of compound 12b to the active site of the COX-2 proteins, which confirmed that compound 12b acted as an anti-inflammatory mediator. These results indicate that steroidal derivatives bearing 4,5-dihydropyrazole thiazole structure might be considered for further research and scaffold optimization in designing anti-inflammatory drugs and compound 12b might be a promising therapeutic anti-inflammatory drug candidate.

Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis

Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold

Synthesis and biological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives for the treatment of inflammatory diseases.

Synthesis and Biological Evaluation of Novel Pyrazoline Derivatives As Potent Anti-Inflammatory Agents

Discovery of a novel inhibitor of nitric oxide production with potential therapeutic effect on acute inflammation

Structural Exploration, Synthesis and Pharmacological Evaluation of Novel 5-Benzylidenethiazolidine-2,4-dione Derivatives As Inos Inhibitors Against Inflammatory Diseases

Anti-inflammatory Efficacy and Relevant SAR Investigations of Novel Chiral Pyrazolo Isoquinoline Derivatives: Design, Synthesis, In-Vitro, In-Vivo, and Computational Studies Targeting Inos

Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation of 6-Aryl-3-amino-thieno[2,3-b]pyridine Derivatives As Potential Anti-Inflammatory Agents.

Design, synthesis and molecular docking of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazole derivatives that act as iNOS/COX-2 inhibitors with potent anti-inflammatory activity against LPS-induced RAW264.7 macrophage cells

Synthesis and biological evaluation of 5-nitropyrimidine-2,4-dione analogues as inhibitors of nitric oxide and iNOS activity.

Acyclic triaryl olefins possessing a sulfohydroxamic acid pharmacophore: synthesis, nitric oxide/nitroxyl release, cyclooxygenase inhibition, and anti-inflammatory studies.

Discovery of novel NSAID hybrids as cPLA 2 /COX-2 dual inhibitors alleviating rheumatoid arthritis via inhibiting p38 MAPK pathway

Discovery of Novel NSAID Hybrids As Cpla2/cox-2 Dual Inhibitors Alleviating Rheumatoid Arthritis Via Inhibiting P38 MAPK Pathway

Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents

Discovery of Novel 2‐(piperidin‐4‐yl)‐1h‐benzo[d]imidazole Derivatives As Potential Anti‐Inflammatory Agents

Design, Synthesis, and Evaluation of the COX-2 Inhibitory Activities of New 1, 3-dihydro-2H-indolin-2-one Derivatives

Discovery of Novel Sesquistilbene Indanone Analogues As Potent Anti-Inflammatory Agents

Discovery and Evaluation of Novel Synthetic 5-Alkyl-4-oxo-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoxaline-1-carbox-amide Derivatives As Anti-Inflammatory Agents

Novel phthalide derivatives: Synthesis and anti-inflammatory activity in vitro and in vivo

Synthesis and Anti-inflammatory Evaluation of Novel 1,2,3-Triazole Derivatives

Discovery of a Potential Anti-Inflammatory Agent: 3-Oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.